Latest News
2017.11.17

Did you know that CTC and Immuneed has a strong partnership with laboratory capacity

Did you know that CTC and Immuneed has a strong partnership with laboratory capacity. The alliance between us provides an opportunity for your early or late candidate drug to be screened either for safety (cytokine release assessment and complement activity) and/or mode-of-action (MOA) studies. In addition our goal is to provide you with an opportunity to assess your candidate drug in a target population. You can read more about the model system in a recent publication published in International Immunopharmacology or contact us for more information

CTC AB: anders.millerhovf@ctc-ab.se

Immuneed: sara.mangsbo@immuneed.com 

Link to the publication:  http://www.sciencedirect.com/science/article/


Back to all News